MedTrace Logo

SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors

NCT07161713 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-23

No results posted yet for this study

Summary

Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness has a positive effect on cancer survivors social, emotional and physical well-being as well as their epigenetics. Epigenetics is how the environment can effect your genes; not by changing our DNA, but by turning genes on or off.

Conditions

  • Lung Adenocarcinoma
  • Lung Adenocarcinoma Metastatic
  • Lung Adenocarcinoma Stage III
  • Lung Adenocarcinoma Stage IIIB/IV
  • Lung Adenocarcinoma Stage IV
  • Lung Adenocarcinoma Stage I
  • Lung Adenocarcinoma Stage II
  • NHL
  • NHL - Non-Hodgkin&Amp;#39;s Lymphoma
  • Lung Cancer (Diagnosis)
  • Colon Cancer

Interventions

BEHAVIORAL

Oncology-informed yoga

8 weekly sessions of cancer informed-yoga incorporating light movement, breathing techniques, and some meditation practices

BEHAVIORAL

SMART

SMART, developed by the Impact Foundation, is an adaptation of Mindfulness-based Stress Reduction (MBSR) approach that incorporates other elements like mindful self-compassion, emotional literacy, and positive psychology principles to address the unique stressors faced by teachers.

Sponsors & Collaborators

  • Barbara Nemesure

    lead OTHER

Principal Investigators

  • Barbara Nemesure, PhD · Stony Brook University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-17
Primary Completion
2027-09-17
Completion
2027-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07161713 on ClinicalTrials.gov